KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 91 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $11,000 | -45.0% | 1,200 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $20,000 | 0.0% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $20,000 | -99.9% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $16,104,000 | +39.8% | 1,200 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $11,520,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 999,275 | $37,403,000 | 55.08% |
| New Leaf Venture Partners, L.L.C. | 126,687 | $4,742,000 | 2.31% |
| Cormorant Asset Management, LP | 385,000 | $14,411,000 | 2.22% |
| SECTORAL ASSET MANAGEMENT INC | 529,920 | $19,835,000 | 0.89% |
| PFM Health Sciences, LP | 850,337 | $31,828,000 | 0.74% |
| Partner Investment Management, L.P. | 16,399 | $614,000 | 0.25% |
| Tekla Capital Management LLC | 137,766 | $5,157,000 | 0.24% |
| Candriam S.C.A. | 298,000 | $11,154,000 | 0.23% |
| Eventide Asset Management | 30,000 | $1,123,000 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 81,047 | $3,034,000 | 0.12% |